Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-?4 antibody in adjuvant arthritis
✍ Scribed by Barbadillo, Carmen ;G-Arroyo, Alicia ;Salas, Clara ;Mulero, Juan ;S�nchez-Madrid, Francisco ;Andreu, JoseL.
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 866 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0344-4325
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## KATAMINE, and SHIGENOBU NAGATAKI Objective. To investigate the association between human T lymphotropic virus type I (HTLV-I) infection and rheumatoid arthritis (RA) in Nagasaki, an area highly endemic for HTLV-I infection. Methods. Sera from 113 female patients with RA and 19,796 female blood
IgG4 comprises a significant proportion of the total anti-Fab antibody (aFABA) response in many but not all patients with rheumatoid arthritis (RA). Analyses of the dynamics of IgG aFABA subclass expression in 11 RA patients for periods of up to 11 months demonstrated that IgG4 aFABA was restricted
## Abstract Anti‐Fab antibody titers were positive in 70% of rheumatoid arthritis patients (54 of 77) and 3% (1 of 35) of healthy donors. Their specificity was examined by inhibition of the radioimmunoassay for anti‐Fab antibodies, which demonstrated that they are against the Fd region of the intac